HighTower Trust’s Gilead Sciences GILD Stock Holding History

HighTower Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$330K	Hold	4,148	–	–	0.03%	181
2022 Q4	$351K	Hold	4,148	–	–	0.03%	174
2022 Q3	$256K	Buy	+4,148	New	+$262K	0.03%	192
2022 Q2	–	Sell	-7,601	Closed	-$452K	–	275
2022 Q1	$452K	Buy	7,601 +44	+0.6%	+$2.81K	0.04%	164
2021 Q4	$549K	Buy	+7,557	New	+$520K	0.05%	147
2020 Q4	–	Sell	-12,158	Closed	-$768K	–	104
2020 Q3	$768K	Sell	12,158 -3,229	-21%	-$224K	0.12%	72
2020 Q2	$1.18M	Sell	15,387 -700	-4%	-$53.6K	0.18%	65
2020 Q1	$1.2M	Buy	16,087 +572	+4%	+$39.5K	0.21%	63
2019 Q4	$1.01M	Sell	15,515 -2,678	-15%	-$174K	0.12%	74
2019 Q3	$1.15M	Buy	18,193 +1,072	+6%	+$70.1K	0.15%	69
2019 Q2	$1.16M	Buy	17,121 +1,727	+11%	+$114K	0.15%	66
2019 Q1	$1M	Buy	15,394 +132	+0.9%	+$8.77K	0.13%	64
2018 Q4	$955K	Sell	15,262 -4,699	-24%	-$328K	0.14%	62
2018 Q3	$1.54M	Buy	19,961 +730	+4%	+$55.1K	0.17%	50
2018 Q2	$1.36M	Buy	+19,231	New	+$1.36M	0.16%	60

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Trust's GILD Position: Q1 2023 in Review

HighTower Trust held its Gilead Sciences (GILD) position steady in Q1 2023 at 4,148 shares worth $330K. The position accounts for 0.03% of the portfolio, ranked #181.

HighTower Trust first reported a position in GILD in Q2 2018 and has held it in 15 quarters since. The position peaked at $1.54M in Q3 2018. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

HighTower Trust held 4,148 shares of Gilead Sciences worth $330K as of Q1 2023.
HighTower Trust left its Gilead Sciences share count unchanged in Q1 2023.
Gilead Sciences made up 0.03% of HighTower Trust's portfolio in Q1 2023, its #181 holding.
HighTower Trust first reported a position in Gilead Sciences in Q2 2018 and has held it in 15 quarters since.
HighTower Trust's Gilead Sciences position peaked at $1.54M in Q3 2018.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.